RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the Company or "RAMM") (CSE: RAMM), announces its intention to commence a normal course issuer bid (the NCIB), under which it may purchase up to 5% of the current number of issued and outstanding common shares of the Company (the Common Shares).